Trevi Therapeutics (TRVI) EBT Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | -27.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.64% |
| Dec 31, 2025 | 26.91% |
| Sep 30, 2025 | 10.97% |
| Jun 30, 2025 | 0.31% |
| Mar 31, 2025 | 5.12% |
| Dec 31, 2024 | -46.08% |
| Sep 30, 2024 | -72.13% |
| Jun 30, 2024 | -72.26% |
| Mar 31, 2024 | -70.26% |
| Dec 31, 2023 | -41.23% |
| Sep 30, 2023 | 6.79% |
| Jun 30, 2023 | 10.94% |
| Mar 31, 2023 | 12.63% |
| Dec 31, 2022 | 35.20% |
| Sep 30, 2022 | -14.06% |
| Jun 30, 2022 | 17.76% |
| Mar 31, 2022 | 12.54% |
| Dec 31, 2021 | 10.31% |
| Sep 30, 2021 | 1.84% |
| Jun 30, 2021 | -32.40% |
| Mar 31, 2021 | 1.13% |
| Dec 31, 2020 | -45.33% |
| Sep 30, 2020 | -0.26% |
| Jun 30, 2020 | -0.65% |
| Mar 31, 2020 | -76.49% |
| Dec 31, 2019 | -8.46% |
| Sep 30, 2019 | -29.78% |
| Jun 30, 2019 | -50.54% |
| Mar 31, 2019 | -17.91% |